Dextera Surgical Inc.
DXTR
DXTR was delisted on the 12th of December, 2017.
25 hedge funds and large institutions have $6.35M invested in Dextera Surgical Inc. in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $9K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Broadfin Capital
New York
|
+$1.77M |
| 2 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$1.72M |
| 3 |
Primecap Management
Pasadena,
California
|
+$1.23M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$987K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$440K |
Top Sellers
DXTR Hedge Fund Activity: Q2 2016 in Review
25 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Dextera Surgical Inc. (DXTR) for Q2 2016, worth a combined $6.35M.
Buyers outnumbered sellers: 25 funds opened new DXTR positions and 0 closed out — a net gain of 25 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Broadfin Capital, opening a new position worth an estimated $1.77M.
- 25 institutional investors held Dextera Surgical Inc. (DXTR) as of Q2 2016, up from 0 in Q1 2016.
- Funds reported $6.35M of Dextera Surgical Inc. stock for Q2 2016.
- 25 funds opened new Dextera Surgical Inc. positions in Q2 2016 and 0 closed out, a net change of +25 holders.
- The largest Dextera Surgical Inc. buyer in Q2 2016 was Broadfin Capital, an estimated $1.77M added.
Based on aggregated 13F filings for Q2 2016.